Thank you. We’ve finally acquired approval for stem cell therapy (regenerative medicine) from the Japanese government.
We’ve finally acquired approval for stem cell therapy (regenerative medicine) from the Japanese government.
Read moreWe’ve finally acquired approval for stem cell therapy (regenerative medicine) from the Japanese government.
Read moreOn November 11, R-Japan Co., Ltd., an affiliate of Nature Cell in Japan, announced that its medical institution partner, Nishihara Clinic, acquired approval for stem cell treatment of critical limb ischemia (CLI) and Buerger’s disease from the Japanese Ministry of Health, Labour and Welfare (MHLW), based on a project initiated by the Biostar Stem Cell Research Institute.
Read moreOn October 8, the Biostar Stem Cell Research Institute, jointly operated by Nature Cell and R Bio, announced that it has completed the application process for acquiring approval for treating degenerative arthritis with regenerative medicine.
Read moreThe Biostar Stem Cell Research Institute, jointly run by Nature Cell and R Bio, announced on September 18 that it has successfully developed the method of separating and culturing stem cells from urine, using independently developed technology.
Read moreOn September 8, the Biostar Stem Cell Research Institute, co-operated by Nature Cell and R Bio, announced that it has completed the application process for acquiring approval of the regenerative medicine treatment method for Buerger’s disease through its medical institution partner in Japan.
Read moreThe Biostar Stem Cell Research Institute wishes to brief you on the progress of the VascoStem and JointStem R&D project at the General Meeting of Shareholders of Nature Cell on September 11, 2015.
Read more
Most Commented